Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Allele Biotechnology and Pharmaceuticals, Inc. v. Regeneron Pharmaceuticals, Inc.
Case Number:
7:20-cv-08255
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 04, 2024
Regeneron Can't Ax Willful Infringement In COVID Patent Case
Regeneron Pharmaceuticals Inc. cannot boot a willful infringement claim from Allele Biotech's patent suit over the development of COVID-19 vaccines and treatments, a New York federal judge ruled Friday, saying it was up to Regeneron to establish that Allele failed to show the defendant had presuit knowledge of the patent.
-
September 19, 2023
Regeneron Partly Agrees It Infringed COVID Tech Patent
Regeneron Pharmaceuticals Inc. has agreed in part that it infringed a California company's patent when developing and testing COVID-19 vaccines and treatments, although it maintained that any liability it may have would not extend to activities covered by a federal safe harbor.
-
March 02, 2022
Regeneron Can't Ditch COVID-19 Tech Patent Suit
Regeneron Pharmaceuticals Inc. can't escape a suit claiming it used poached technology in its development and testing of COVID-19 vaccines and treatments, a New York federal judge ruled Wednesday.
-
August 20, 2021
Regeneron Wants COVID-19 Tech Patent Suit Axed
Regeneron Pharmaceuticals Inc. wants a New York federal judge to toss a suit claiming it used poached technology in its development and testing of COVID-19 vaccines and treatments, saying the company is protected by a legal safe harbor.
-
October 09, 2020
COVID-19 IP Catch-Up: Moderna Promises & Ed Sheeran
In this round of intellectual property updates tied to the COVID-19 pandemic, Moderna said it would hold off on enforcing certain patents and Ed Sheeran said getting to the U.S. for a copyright trial may be impossible, among many other litigation updates.
-
October 05, 2020
Pfizer, Regeneron Hit With Patent Suits Over COVID-19 Tech
Pfizer Inc. and Regeneron Pharmaceuticals Inc. were accused Monday of using poached technology in their development and testing of COVID-19 vaccines and treatments, according to a pair of patent infringement suits lodged in California and New York federal court.